Norwegian Scholarships for the Master's and Doctoral Programs

Chu, J.H. , Gange, S.J. , Anastos, K. , Minkoff, H. , Cejtin, H. , Bacon, M. , Levine, A. and Greenblatt, R.M. (2005) ‘ Hormonal Contraceptive Use and the Effectiveness of Highly Active Antiretroviral Therapy ,’ American Journal of Epidemiology 161 (9): 881–90 .

Cohn, S. , Watts, D. , Lertora, J. , Park, J.G. and Yu, S. (2005) ‘ An Open-label, Nonrandomised Study of the Effect of Depo-medroxyprogesterone Acetate on the Pharmacokinetics of Selected Protease Inhibitors and Non-nucleoside Reverse Transcriptase Inhibitors Therapies among HIV-infected Women ,’ Presented at the 12th Conference on Retroviruses and Opportunistic Infections, Boston, February 22–25.

Mildvan, D. , Yarrish, R. , Marshak, A. , Hutman, H.W. , McDonough, M. , Lamson, M. and Robinson, P. (2002) ‘ Pharmacokinetic Interaction between Nevirapine and Ethinyl Estradiol/norethindrone when Administered Concurrently to HIV-infected Women ,’ Journal of Acquired Immune Deficiency Syndromes 29 (5): 471–77 .

Money, D.M. (2003) ‘ Antiviral and Antiretroviral Use in Pregnancy ,’ Obstetrics and Gynecology Clinics of North America 30 (4): 731–49 .

Piscitelli, S.C. and Gallicano, K.D. (2001) ‘ Interactions among Drugs for HIV and Opportunistic Infections ,’ New England Journal of Medicine 344 (13): 984–96 .

Preble, E.A. , Huber, D. and Piwoz, E.G. (2003) ‘Family Planning and the Prevention of Mother-to-child Transmission of HIV: Technical and Programmatic Issues,’ Arlington, Virginia, Advance Africa , February 21, 38 pp. (Available at http://www.advanceafrica.org/publications_and_presentations/Technical_Papers/TP_FP_and_PMTCT.pdf)

Shelton, J.D. (2005) ‘Contraception for Women on First-line Antiretrovirals (ARVs),’ Baltimore, The INFO Project at the Johns Hopkins Bloomberg School of Public Health/ Center for Communication Programs, March 25 (Global Health Technical Briefs) (Available: http://www.maqweb.org/techbriefs/tb5arv.shtml).

World Health Organization (WHO) (1986). A Multicentered Phase III Comparative Clinical Trial of Depot-medroxyprogesterone Acetate Given in Three-monthly at Doses of 100mg or 150mg: I. Contraceptive Efficacy and Side Effects ,’ Contraception 34 (3): 223–35 .

World Health Organization (WHO) (2004) ‘Scaling up Antiretroviral Therapy in Resource-limited Settings: Treatment Guidelines for a Public Health Approach. Geneva , WHO, 68 pp. (Available at http://www.who.int/hiv/pub/prev_care/en/arvrevision2003en.pdf)